Onyx Pharmaceuticals buy wiltrud
Start price
30.03.12
/
50%
€28.37
Target price
25.04.12
€34.50
Performance (%)
23.94%
End price
25.04.12
€35.16
Summary
This prediction ended on 25.04.12 with a price of €35.16. The prediction had a final performance of 23.94%. wiltrud has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Onyx Pharmaceuticals | - | - | - | - |
| iShares Core DAX® | -0.793% | 4.201% | 19.951% | 70.602% |
| iShares Nasdaq 100 | -2.376% | 0.857% | 4.704% | 103.322% |
| iShares Nikkei 225® | -2.701% | -0.147% | 12.609% | 44.593% |
| iShares S&P 500 | -1.689% | 1.244% | 3.144% | 64.741% |
Comments by wiltrud for this prediction
In the thread Onyx Pharmaceuticals diskutieren
Bekommt Onyx die zweite Zulassung ?
kalifornische Biotech-Unternehmen steht vor der Zulassung seines zweiten Medikaments. Ein Erfolg könnte zu steigenden Kursen führen.
<!-- /BLOCK 4 -->